|
38
|
218
|
1fmd2 |
The structure and antigenicity of a type c foot-and-mouth disease virus |
|
56
|
250
|
1fpn2 |
Human rhinovirus serotype 2 (hrv2) |
|
0
|
11
|
1fptP |
Three-dimensional structure of the complex between the fab fragment of an neutralizing antibody for type 1 poliovirus and its viral epitope |
|
51
|
281
|
1ev11 |
Echovirus 1 |
|
43
|
239
|
1ev13 |
Echovirus 1 |
|
3
|
71
|
1fmd4 |
The structure and antigenicity of a type c foot-and-mouth disease virus |
|
55
|
254
|
1ev12 |
Echovirus 1 |
|
4
|
68
|
1ev14 |
Echovirus 1 |
|
58
|
262
|
1eah2 |
Pv2l complexed with antiviral agent sch48973 |
|
37
|
235
|
1eah3 |
Pv2l complexed with antiviral agent sch48973 |
|
0
|
13
|
1ejoP |
Fab fragment of neutralising monoclonal antibody 4c4 complexed with g-h loop from fmdv. |
|
6
|
68
|
1eah4 |
Pv2l complexed with antiviral agent sch48973 |
|
43
|
278
|
1eah1 |
Pv2l complexed with antiviral agent sch48973 |
|
4
|
68
|
1d4m4 |
The crystal structure of coxsackievirus a9 to 2.9 a resolution |
|
48
|
252
|
1d4m2 |
The crystal structure of coxsackievirus a9 to 2.9 a resolution |
|
51
|
284
|
1d4m1 |
The crystal structure of coxsackievirus a9 to 2.9 a resolution |
|
41
|
238
|
1d4m3 |
The crystal structure of coxsackievirus a9 to 2.9 a resolution |
|
3
|
68
|
1cov4 |
Coxsackievirus b3 coat protein |
|
43
|
256
|
1cov2 |
Coxsackievirus b3 coat protein |
|
33
|
238
|
1cov3 |
Coxsackievirus b3 coat protein |
|
41
|
269
|
1cov1 |
Coxsackievirus b3 coat protein |
|
43
|
180
|
1cqqA |
Type 2 rhinovirus 3c protease with ag7088 inhibitor |
|
60
|
285
|
1c8m1 |
Refined crystal structure of human rhinovirus 16 complexed with vp63843 (pleconaril), an anti-picornaviral drug currently in clinical trials |
|
3
|
44
|
1c8m4 |
Refined crystal structure of human rhinovirus 16 complexed with vp63843 (pleconaril), an anti-picornaviral drug currently in clinical trials |
|
59
|
252
|
1c8m2 |
Refined crystal structure of human rhinovirus 16 complexed with vp63843 (pleconaril), an anti-picornaviral drug currently in clinical trials |
|
35
|
238
|
1c8m3 |
Refined crystal structure of human rhinovirus 16 complexed with vp63843 (pleconaril), an anti-picornaviral drug currently in clinical trials |
|
3
|
40
|
1bev4 |
Bovine enterovirus vg-5-27 |
|
61
|
252
|
1aym2 |
Human rhinovirus 16 coat protein at high resolution |
|
42
|
235
|
1ar83 |
P1/mahoney poliovirus, mutant p1095s |
|
3
|
68
|
1ar94 |
P1/mahoney poliovirus, single site mutant h2142y |
|
44
|
235
|
1ar73 |
P1/mahoney poliovirus, double mutant p1095s + h2142y |
|
44
|
283
|
1ar91 |
P1/mahoney poliovirus, single site mutant h2142y |
|
1
|
44
|
1ayn4 |
Human rhinovirus 16 coat protein |
|
59
|
268
|
1asj2 |
P1/mahoney poliovirus, at cryogenic temperature |
|
45
|
235
|
1ar93 |
P1/mahoney poliovirus, single site mutant h2142y |
|
41
|
235
|
1asj3 |
P1/mahoney poliovirus, at cryogenic temperature |
|
37
|
242
|
1bev3 |
Bovine enterovirus vg-5-27 |
|
46
|
283
|
1ar81 |
P1/mahoney poliovirus, mutant p1095s |
|
42
|
268
|
1bev1 |
Bovine enterovirus vg-5-27 |
|
39
|
238
|
1ayn3 |
Human rhinovirus 16 coat protein |
|
2
|
68
|
1ar64 |
P1/mahoney poliovirus, double mutant v1160i +p1095s |
|
5
|
68
|
1ar84 |
P1/mahoney poliovirus, mutant p1095s |
|
3
|
68
|
1asj4 |
P1/mahoney poliovirus, at cryogenic temperature |
|
61
|
285
|
1aym1 |
Human rhinovirus 16 coat protein at high resolution |
|
47
|
283
|
1ar71 |
P1/mahoney poliovirus, double mutant p1095s + h2142y |
|
49
|
244
|
1bev2 |
Bovine enterovirus vg-5-27 |
|
58
|
285
|
1ayn1 |
Human rhinovirus 16 coat protein |
|
65
|
268
|
1ar92 |
P1/mahoney poliovirus, single site mutant h2142y |
|
44
|
235
|
1ar63 |
P1/mahoney poliovirus, double mutant v1160i +p1095s |
|
59
|
252
|
1ayn2 |
Human rhinovirus 16 coat protein |
